The treatment pipeline: moving beyond “Making the most of what we’ve got”
Looking to the future of TB treatment.
South Africa is coughing up too much money for DR-TB treatment
Over a year ago, on October 30, 2014, three young South Africans whose lives were profoundly affected by their battle with extensively drug-resistant tuberculosis (XDR-TB) led a group of supporters to the offices of the country’s regulator, the Medicines Control Council (MCC), to make an urgent plea.
Resisting stock-outs
ARV stock-outs leads to treatment interruptions in those living with HIV/AIDS which could have serious knock-on effects and may lead to death.
GeneXpert: The first five years
In December 2010 the World Health Organisation recommended that countries start using a breakthrough new TB test called Xpert MTB/RIF (commonly referred to as GeneXpert). South Africa rapidly embraced this…
Will BRICS countries step up to the challenge of finding new TB medicines?
Tuberculosis is a classic poor person’s disease – a limited problem in the United States and Western Europe, but killing hundreds of thousands of people every year in countries like…
Foolish to try and fix TB without fixing health systems
This issue of the NSP Review has been published to coincide with the 46th Union World Conference on Lung Health in Cape Town. TAC and SECTION27 welcome all foreign delegates…
Motsoaledi’s curse: When politics trumps health, people pay the price
NSP Review COMMENT It is a curable disease. It is a treatable disease. Yet, it has managed to devastate health systems and communities for centuries. When HIV arrived, this wily…
One patient, one nurse, one file – it isn’t that hard
I thought the struggle for TB/HIV integration was over. We won. ‘TB and HIV and AIDS will now be treated under one roof.’ These were the exact words of President…